Innovation and research for the future

  • Immunostep News
    New SARS-CoV-2 Multiplex Assay By Flow Cytometry

    Monitoring SARS-CoV-2 with high specificity and sensitivity. The most complete serological solution in the market so far. 

  • Immunostep News
    We launch our new Exosome Website

    Discover Everything about Exosomes and unlock the potential of these EVs as minimum invasive liquid biopsis. 

  • Immunostep News
    White Paper: Exosome Detection and Characterization by Flow Cytometry.

    Download Free the white paper about a kit for the detection and characterization of Exosomes by Flow Cytometry.

  • Immunostep News
    Watch again our talk at LatinFlow 2021

    II Congreso Virtual Iberoamericano de Citometría. Latinflow 2021. Watch our talk about Covid-19 serology by flow cytometry! 

    Driving Biomedical Research and Diagnosis Since 2001

    At immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve performance in key areas of clinical research and diagnostic development. Our goal is to improve research and diagnostic performance by innovating and adapting new technology to collaborate building meaningful clinical investigation. 

    Leading-edge research products to increase the analysis potential.

    Extensive Research, Development and Innovation (R&D&I) Programme.

    Seeking efficency and offering alternative to traditional solutions.

    Succesful technology licensing and meaningful worldwide collaborations.

    Biotechnology Innovation

    We work to achieve customer satisfaction through quality and differentiation of our products. We are constantly learning and developing as a company and, in the same way, we expect our products and our way of working to be constantly improving for the benefit of all our collaborators. 


    At the leading-edge of technology in research areas of development

    We find the most innovative technology and use them to build adaptive clinical products to diagnose and treat diseases, and we work to achieve our goals under a strict system of values:

    Unceasing innovation

    We seek always to be at the leading-edge of technology in research areas of development, and in order to achieve that goal, we work under an aggressive R&D program headed by a brilliant scientific team. 

    Commitment to science and technology

    Immunostep has a strong support for a renewal of investment in science and technology in order to support the development of the scientific community and its research efforts on a global scale. 

    Highest Quality standard

    Intensifying our commitment of providing high quality products, Immunostep works under an ISO 13485:2016 certified quality management system, which meets international standards for medical device and reagent manufacturing. 

    Social and Environmental commitment

    The social  wellbeing of our employees, suppliers and local communities is our concern as a responsible overall activity. We evaluate the environmental and social impacts of all of the projects we invest in and work with our clients to achieve good international standards. 

    Unlocking the Potential of Exosomes

    In 2017 Immunostep I+D team recognized the great potential of exosomes and since then we have been working on the development of a method for detecting, isolate and quantifying extracellular vesicles which are present in fluid samples.  

    Learn the latest from Immunostep

    Subscribe to our Newsletter and discover everything about our latest Press Releases, Publications, Media Resources, Webinars & Events and much more.

      I have read the terms and conditions of the Privacy Policy and accept the terms.

      Improving SARS-CoV-2 Serology Testing Performance

      As a response to SARs-CoV-2 global emergency we have developed a product line in order to improve serological testing performance and help building clinical investigation around Covid-19 disease. 


      For any information required, please use the form below and we will contact you shortly. 

        I have read the Privacy Policy and accept the terms.
        I would like to recive occasional News and Updates.